173 related articles for article (PubMed ID: 10602434)
1. Primary non-Hodgkin's lymphoma of bone: a clinicopathological investigation of 60 cases.
Heyning FH; Hogendoorn PC; Kramer MH; Hermans J; Kluin-Nelemans JC; Noordijk EM; Kluin PM
Leukemia; 1999 Dec; 13(12):2094-8. PubMed ID: 10602434
[TBL] [Abstract][Full Text] [Related]
2. Primary lymphoma of bone: a prospective study of 28 cases.
Brousse C; Baumelou E; Morel P
Joint Bone Spine; 2000; 67(5):446-51. PubMed ID: 11143912
[TBL] [Abstract][Full Text] [Related]
3. Subclassification of diffuse large B-cell lymphomas according to the Kiel classification: distinction of centroblastic and immunoblastic lymphomas is a significant prognostic risk factor.
Engelhard M; Brittinger G; Huhn D; Gerhartz HH; Meusers P; Siegert W; Thiel E; Wilmanns W; Aydemir U; Bierwolf S; Griesser H; Tiemann M; Lennert K
Blood; 1997 Apr; 89(7):2291-7. PubMed ID: 9116271
[TBL] [Abstract][Full Text] [Related]
4. Progress in the management of high risk non-Hodgkin's lymphomas. 10 years of experience of the 3rd Medical Department of Hanusch Hospital, Vienna.
Heinz R; Hanak H; Stacher A
Klin Wochenschr; 1985 Jul; 63(14):619-26. PubMed ID: 3839867
[TBL] [Abstract][Full Text] [Related]
5. [Treatment outcome in primary testicular non-Hodgkin lymphoma].
Iványi JL; Marton E; Plander M; Engert ZV; Tóth C
Orv Hetil; 2013 Oct; 154(42):1666-73. PubMed ID: 24121219
[TBL] [Abstract][Full Text] [Related]
6. Effect of treatment on the prognostic value of S-phase fraction in non-Hodgkin's lymphoma.
Joensuu H; Ristamäki R; Söderström KO; Jalkanen S
J Clin Oncol; 1994 Oct; 12(10):2167-75. PubMed ID: 7931487
[TBL] [Abstract][Full Text] [Related]
7. Primary bone lymphoma: a retrospective analysis.
Horsman JM; Thomas J; Hough R; Hancock BW
Int J Oncol; 2006 Jun; 28(6):1571-5. PubMed ID: 16685458
[TBL] [Abstract][Full Text] [Related]
8. Primary non-Hodgkin lymphoma of bone: an unusual presentation.
Pinheiro RF; Filho FD; Lima GG; Ferreira FV
J Cancer Res Ther; 2009; 5(1):52-3. PubMed ID: 19293492
[TBL] [Abstract][Full Text] [Related]
9. [Clinical features, treatment and prognosis of 136 patients with primary non-Hodgkin's lymphoma of the nasopharynx].
Yuan ZY; Li YX; Zhao LJ; Gao YH; Liu XF; Gu DZ; Qian TN; Yu ZH
Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):425-9. PubMed ID: 15355649
[TBL] [Abstract][Full Text] [Related]
10. Primary lymphoma of bone: experience of 39 cases at the Tata Memorial Hospital, India.
Susnerwala SS; Dinshaw KA; Pande SC; Shrivastava SK; Gonsalves MA; Advani SH; Gopal R
J Surg Oncol; 1990 Aug; 44(4):229-33. PubMed ID: 2385100
[TBL] [Abstract][Full Text] [Related]
11. Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomas.
Schlembach PJ; Wilder RB; Tucker SL; Ha CS; Rodriguez MA; Hess MA; Cabanillas FF; Cox JD
Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1107-10. PubMed ID: 11072169
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group.
Conlan MG; Bast M; Armitage JO; Weisenburger DD
J Clin Oncol; 1990 Jul; 8(7):1163-72. PubMed ID: 1694234
[TBL] [Abstract][Full Text] [Related]
13. Tumor bulk as a prognostic factor for the management of localized aggressive non-Hodgkin's lymphoma: a survey of the Japan Lymphoma Radiation Therapy Group.
Oguchi M; Ikeda H; Isobe K; Hirota S; Hasegawa M; Nakamura K; Sasai K; Hayabuchi N
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):161-8. PubMed ID: 10924986
[TBL] [Abstract][Full Text] [Related]
14. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity].
Yao B; Li YX; Song YW; Jin J; Liu YP; Wang WH; Wang SL; Sun YT; Yu ZH; Liu XF
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):58-61. PubMed ID: 16737624
[TBL] [Abstract][Full Text] [Related]
15. Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP
Borchmann P; Haverkamp H; Lohri A; Mey U; Kreissl S; Greil R; Markova J; Feuring-Buske M; Meissner J; Dührsen U; Ostermann H; Keller U; Maschmeyer G; Kuhnert G; Dietlein M; Kobe C; Eich H; Baues C; Stein H; Fuchs M; Diehl V; Engert A
Lancet Oncol; 2017 Apr; 18(4):454-463. PubMed ID: 28236583
[TBL] [Abstract][Full Text] [Related]
16. Malignant lymphoma of bone.
Dürr HR; Müller PE; Hiller E; Maier M; Baur A; Jansson V; Refior HJ
Arch Orthop Trauma Surg; 2002 Feb; 122(1):10-6. PubMed ID: 11995873
[TBL] [Abstract][Full Text] [Related]
17. EORTC trial non-Hodgkin lymphomas.
Somers R; Burgers JM; Qasim M; Van Glabbeke M; Duez N; Hayat M
Eur J Cancer Clin Oncol; 1987 Mar; 23(3):283-93. PubMed ID: 3297719
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological features and prognostic factors in extranodal non-Hodgkin lymphomas. Danish LYFO Study Group.
d'Amore F; Christensen BE; Brincker H; Pedersen NT; Thorling K; Hastrup J; Pedersen M; Jensen MK; Johansen P; Andersen E
Eur J Cancer; 1991; 27(10):1201-8. PubMed ID: 1835586
[TBL] [Abstract][Full Text] [Related]
19. Non-Hodgkin's lymphomas in Turkey: eighteen years' experience at the Hacettepe University.
Barista I; Tekuzman G; Firat D; Baltali E; Kansu E; Kars A; Ozisik Y; Ruacan S; Uzunalimoğlu B; Karaağaoğlu E
Jpn J Cancer Res; 1994 Dec; 85(12):1200-7. PubMed ID: 7531679
[TBL] [Abstract][Full Text] [Related]
20. Advanced diffuse non-Hodgkin's lymphoma. Analysis of prognostic factors by the international index and by lactic dehydrogenase in an intergroup study.
Gordon LI; Andersen J; Colgan J; Glick J; Resnick GD; O'Connell M; Cassileth PA
Cancer; 1995 Feb; 75(3):865-73. PubMed ID: 7530168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
